RE:RE:RE:RE:RE:Official termination of distribution rights in Europe It's crazy. If they make a positive forward looking statements and it doesn't pan out they get kicked (NASH).
If they say nothing, wait for the picture to become clearer before saying something they get kicked (cancer).
They (and us) are trying to deal with the uncertainty of biotech (it's a big part of the story). I don't know either are doing a good job of it. Ultimately success is the only real answer, that's eluded them in their last two projects (Trogarzo and NASH). It's coming slow (if at all) in cancer, that might change rapidly for the better or worse or it might not. I'm still hopeful.
Biobob wrote: That and the STRONG negociation position in P3 NASH/Partner.. we now are loonking at P2/3 and no partner like a year later. No wonder they don't tell us anything about the cancer trial, maybe they learned it's better this way since they never make the deadline. As long as they succeed in the end. At that point averything that was said on this board will vanish in oblivion and a new era will begin... amen.